If you’ve been diagnosed with sleep apnea, it means your breathing gets shallow or even stops and restarts while you’re asleep. Often, the first treatment your doctor may have you try is a device to ...
-- The Simple, No-cost Test Can Detect Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Autoantibodies in the Blood with Only a Finger Prick -- The DBS test demonstrates a high correlation ...
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, recently launched aPAP ClearPath™, a new ...
LANGHORNE, Pa., October 22, 2024--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced that a new ...
Oppenheimer raised the firm’s price target on Savara (SVRA) to $8 from $6 and keeps an Outperform rating on the shares following updated analysis pointing to 5,500 aPAP patients in the U.S. from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results